Primary Pseudomyogenic Hemangioendothelioma of Bone

Alero Inyang, Fredrik Mertens, Florian Puls, Vaiyapuri Sumathi, Carrie Inwards, Andrew Folpe, Cheng Han Lee, Yaxia Zhang, Pennie Symmans, Brian Rubin, Gunnlaugur P. Nielsen, Van Hung Nguyen, Andrew Rosenberg

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pseudomyogenic hemangioendothelioma (PMH) is a well-recognized neoplasm that usually arises in the soft tissue; concurrent bone involvement occurs in 24% of cases. PMH of bone without soft tissue involvement is rare. We describe the clinicopathologic findings of 10 such cases, the largest series reported to date. The study included 9 male and 1 female patient; their ages ranged from 12 to 74 years (mean 36.7 y). All patients had multiple tumors with a distinct regional distribution: 45% restricted to the lower extremity; 25% to the spine and pelvis; and 15% to the upper extremity. On imaging studies the tumors were well circumscribed and lytic. The neoplasms were composed of spindled cells arranged in intersecting fascicles with scattered epithelioid cells; epithelioid cells predominated in 3 cases. The neoplastic cells contained abundant densely eosinophilic cytoplasm and vesicular nuclei. There was limited cytologic atypia and necrosis, few mitoses (0 to 2/10 high-power fields), and inconspicuous stroma. Unique findings included abundant intratumoral reactive woven bone and hemorrhage with numerous osteoclast-like giant cells. Immunohistochemically, most tumors were positive for keratin, ERG, and CD31; CD34 was negative. The balanced t(7:19)(q22;13) translocation was documented in 3 cases. Follow-up is limited, but no patient developed documented visceral dissemination, and all have stable or progressive osseous disease. PMH exclusively involving bone is rare. It is multicentric, often involves the lower extremity, and has unusual morphology. The differential diagnosis includes epithelioid vascular neoplasms, giant cell tumor, bone forming neoplasms, and metastatic carcinoma. Because of its rarity, unusual presentation, and morphology, accurate diagnosis can be challenging.

Original languageEnglish (US)
JournalAmerican Journal of Surgical Pathology
DOIs
StateAccepted/In press - Feb 11 2016

Fingerprint

Hemangioendothelioma
Bone and Bones
Epithelioid Cells
Neoplasms
Lower Extremity
Vascular Neoplasms
Giant Cell Tumor of Bone
Bone Neoplasms
Osteoclasts
Giant Cells
Keratins
Pelvis
Mitosis
Upper Extremity
Cytoplasm
Spine
Differential Diagnosis
Necrosis
Hemorrhage
Carcinoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Primary Pseudomyogenic Hemangioendothelioma of Bone. / Inyang, Alero; Mertens, Fredrik; Puls, Florian; Sumathi, Vaiyapuri; Inwards, Carrie; Folpe, Andrew; Lee, Cheng Han; Zhang, Yaxia; Symmans, Pennie; Rubin, Brian; Nielsen, Gunnlaugur P.; Nguyen, Van Hung; Rosenberg, Andrew.

In: American Journal of Surgical Pathology, 11.02.2016.

Research output: Contribution to journalArticle

Inyang, A, Mertens, F, Puls, F, Sumathi, V, Inwards, C, Folpe, A, Lee, CH, Zhang, Y, Symmans, P, Rubin, B, Nielsen, GP, Nguyen, VH & Rosenberg, A 2016, 'Primary Pseudomyogenic Hemangioendothelioma of Bone', American Journal of Surgical Pathology. https://doi.org/10.1097/PAS.0000000000000613
Inyang, Alero ; Mertens, Fredrik ; Puls, Florian ; Sumathi, Vaiyapuri ; Inwards, Carrie ; Folpe, Andrew ; Lee, Cheng Han ; Zhang, Yaxia ; Symmans, Pennie ; Rubin, Brian ; Nielsen, Gunnlaugur P. ; Nguyen, Van Hung ; Rosenberg, Andrew. / Primary Pseudomyogenic Hemangioendothelioma of Bone. In: American Journal of Surgical Pathology. 2016.
@article{d1494eac81d441679aa0f11881e7bac1,
title = "Primary Pseudomyogenic Hemangioendothelioma of Bone",
abstract = "Pseudomyogenic hemangioendothelioma (PMH) is a well-recognized neoplasm that usually arises in the soft tissue; concurrent bone involvement occurs in 24{\%} of cases. PMH of bone without soft tissue involvement is rare. We describe the clinicopathologic findings of 10 such cases, the largest series reported to date. The study included 9 male and 1 female patient; their ages ranged from 12 to 74 years (mean 36.7 y). All patients had multiple tumors with a distinct regional distribution: 45{\%} restricted to the lower extremity; 25{\%} to the spine and pelvis; and 15{\%} to the upper extremity. On imaging studies the tumors were well circumscribed and lytic. The neoplasms were composed of spindled cells arranged in intersecting fascicles with scattered epithelioid cells; epithelioid cells predominated in 3 cases. The neoplastic cells contained abundant densely eosinophilic cytoplasm and vesicular nuclei. There was limited cytologic atypia and necrosis, few mitoses (0 to 2/10 high-power fields), and inconspicuous stroma. Unique findings included abundant intratumoral reactive woven bone and hemorrhage with numerous osteoclast-like giant cells. Immunohistochemically, most tumors were positive for keratin, ERG, and CD31; CD34 was negative. The balanced t(7:19)(q22;13) translocation was documented in 3 cases. Follow-up is limited, but no patient developed documented visceral dissemination, and all have stable or progressive osseous disease. PMH exclusively involving bone is rare. It is multicentric, often involves the lower extremity, and has unusual morphology. The differential diagnosis includes epithelioid vascular neoplasms, giant cell tumor, bone forming neoplasms, and metastatic carcinoma. Because of its rarity, unusual presentation, and morphology, accurate diagnosis can be challenging.",
author = "Alero Inyang and Fredrik Mertens and Florian Puls and Vaiyapuri Sumathi and Carrie Inwards and Andrew Folpe and Lee, {Cheng Han} and Yaxia Zhang and Pennie Symmans and Brian Rubin and Nielsen, {Gunnlaugur P.} and Nguyen, {Van Hung} and Andrew Rosenberg",
year = "2016",
month = "2",
day = "11",
doi = "10.1097/PAS.0000000000000613",
language = "English (US)",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Primary Pseudomyogenic Hemangioendothelioma of Bone

AU - Inyang, Alero

AU - Mertens, Fredrik

AU - Puls, Florian

AU - Sumathi, Vaiyapuri

AU - Inwards, Carrie

AU - Folpe, Andrew

AU - Lee, Cheng Han

AU - Zhang, Yaxia

AU - Symmans, Pennie

AU - Rubin, Brian

AU - Nielsen, Gunnlaugur P.

AU - Nguyen, Van Hung

AU - Rosenberg, Andrew

PY - 2016/2/11

Y1 - 2016/2/11

N2 - Pseudomyogenic hemangioendothelioma (PMH) is a well-recognized neoplasm that usually arises in the soft tissue; concurrent bone involvement occurs in 24% of cases. PMH of bone without soft tissue involvement is rare. We describe the clinicopathologic findings of 10 such cases, the largest series reported to date. The study included 9 male and 1 female patient; their ages ranged from 12 to 74 years (mean 36.7 y). All patients had multiple tumors with a distinct regional distribution: 45% restricted to the lower extremity; 25% to the spine and pelvis; and 15% to the upper extremity. On imaging studies the tumors were well circumscribed and lytic. The neoplasms were composed of spindled cells arranged in intersecting fascicles with scattered epithelioid cells; epithelioid cells predominated in 3 cases. The neoplastic cells contained abundant densely eosinophilic cytoplasm and vesicular nuclei. There was limited cytologic atypia and necrosis, few mitoses (0 to 2/10 high-power fields), and inconspicuous stroma. Unique findings included abundant intratumoral reactive woven bone and hemorrhage with numerous osteoclast-like giant cells. Immunohistochemically, most tumors were positive for keratin, ERG, and CD31; CD34 was negative. The balanced t(7:19)(q22;13) translocation was documented in 3 cases. Follow-up is limited, but no patient developed documented visceral dissemination, and all have stable or progressive osseous disease. PMH exclusively involving bone is rare. It is multicentric, often involves the lower extremity, and has unusual morphology. The differential diagnosis includes epithelioid vascular neoplasms, giant cell tumor, bone forming neoplasms, and metastatic carcinoma. Because of its rarity, unusual presentation, and morphology, accurate diagnosis can be challenging.

AB - Pseudomyogenic hemangioendothelioma (PMH) is a well-recognized neoplasm that usually arises in the soft tissue; concurrent bone involvement occurs in 24% of cases. PMH of bone without soft tissue involvement is rare. We describe the clinicopathologic findings of 10 such cases, the largest series reported to date. The study included 9 male and 1 female patient; their ages ranged from 12 to 74 years (mean 36.7 y). All patients had multiple tumors with a distinct regional distribution: 45% restricted to the lower extremity; 25% to the spine and pelvis; and 15% to the upper extremity. On imaging studies the tumors were well circumscribed and lytic. The neoplasms were composed of spindled cells arranged in intersecting fascicles with scattered epithelioid cells; epithelioid cells predominated in 3 cases. The neoplastic cells contained abundant densely eosinophilic cytoplasm and vesicular nuclei. There was limited cytologic atypia and necrosis, few mitoses (0 to 2/10 high-power fields), and inconspicuous stroma. Unique findings included abundant intratumoral reactive woven bone and hemorrhage with numerous osteoclast-like giant cells. Immunohistochemically, most tumors were positive for keratin, ERG, and CD31; CD34 was negative. The balanced t(7:19)(q22;13) translocation was documented in 3 cases. Follow-up is limited, but no patient developed documented visceral dissemination, and all have stable or progressive osseous disease. PMH exclusively involving bone is rare. It is multicentric, often involves the lower extremity, and has unusual morphology. The differential diagnosis includes epithelioid vascular neoplasms, giant cell tumor, bone forming neoplasms, and metastatic carcinoma. Because of its rarity, unusual presentation, and morphology, accurate diagnosis can be challenging.

UR - http://www.scopus.com/inward/record.url?scp=84957900667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957900667&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000613

DO - 10.1097/PAS.0000000000000613

M3 - Article

C2 - 26872012

AN - SCOPUS:84957900667

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

ER -